Neurosearch A/S Announces The Danish Business Authority’s Decision In The Accounting Control Matter

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NeuroSearch A/S (NEUR) announces that the Danish Business Authority has made a decision concerning the control of the company’s annual report for the financial year 2012.

In its decision, the Danish Business Authority points out that in the 2012 financial statements NeuroSearch incorrectly classified the proceeds from the sale of the Huntexil®project as revenue, in that the proceeds ought to have been classified as gain from divestment of intellectual property.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC